186 related articles for article (PubMed ID: 24472803)
1. Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients.
Streiff MB
Clin Adv Hematol Oncol; 2013 Jun; 11(6):349-57. PubMed ID: 24472803
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
3. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
4. Primary prophylaxis of VTE in cancer outpatients.
Imberti D; Benedetti R
Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in Lymphoma Patients and in Myeloma Patients.
Yokoyama K
Keio J Med; 2015; 64(3):37-43. PubMed ID: 26212069
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M; Russo L
Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.
Wun T; White RH
Thromb Res; 2010 Apr; 125 Suppl 2():S96-102. PubMed ID: 20434017
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in patients with myeloma: incidence and risk factors in a "real-world" population.
Crowley MP; Eustace JA; O'Shea SI; Gilligan OM
Clin Appl Thromb Hemost; 2014 Sep; 20(6):600-6. PubMed ID: 24486624
[TBL] [Abstract][Full Text] [Related]
9. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
White RH; Chew H; Wun T
Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
[TBL] [Abstract][Full Text] [Related]
10. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M
J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
Anaissie EJ; Coleman EA; Goodwin JA; Kennedy RL; Lockhart KD; Stewart CB; Coon SK; Bailey C; Barlogie B
Cancer; 2012 Jan; 118(2):549-57. PubMed ID: 21720994
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.
Zamagni E; Brioli A; Tacchetti P; Zannetti B; Pantani L; Cavo M
Semin Thromb Hemost; 2011 Apr; 37(3):209-19. PubMed ID: 21455855
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
20. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
